Approval · Notice of Compliance 2617 · 2001
VARIZIG: Notice of Compliance 2617
Issued January 18, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2617
- Date
- January 18, 2001
- Company
- Cangene Corporation
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Passive immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VARIZIG | 02243342 | Cancelled Post Market |
Medicinal ingredients
- VARICELLA ZOSTER IMMUNOGLOBULIN (HUMAN) 125 UNIT per VIAL